Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Index

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

			For the transition period from ________________ to ________________

Commission File No.: 001-15465

Intellicheck, Inc.

(Exact name of Registrant as specified in its charter)


Delaware						11-3234779
(State or Other Jurisdiction of Incorporation or Organization)						(I.R.S. Employer Identification No.)

200 Broadhollow Road, Suite 207, Melville, NY 11747
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (516) 992-1900

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common stock, $0.001 par value per share

IDN

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.) Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer ☐

Smaller reporting company

☒

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 14, 2023, there were 19,354,335 shares of Common Stock, $0.001 par value, outstanding.

Index

INTELLICHECK, INC.

Index


			Page
PART I – FINANCIAL INFORMATION			3

Item 1. Unaudited Condensed Financial Statements			3

Condensed Balance Sheets – September 30, 2023 (Unaudited) and December 31, 2022			3

Unaudited Condensed Statements of Operations for the three and nine months ended September 30, 2023 and 2022			4

Unaudited Condensed Statements of Stockholders’ Equity for the three and nine months ended September 30, 2023 and 2022			6

Unaudited Condensed Statements of Cash Flows for the nine months ended September 30, 2023 and 2022			7

Notes to Unaudited Condensed Financial Statements			8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			22

Item 3. Quantitative and Qualitative Disclosures About Market Risk			26

Item 4. Controls and Procedures			26

Part II – OTHER INFORMATION			27

Item 1. Legal Proceedings			27

Item 1A. Risk Factors			27

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			27

Item 3. Defaults Upon Senior Securities			27

Item 4. Mine Safety Disclosures			28

Item 5. Other Information			28

Item 6. Exhibits			28

Signatures			29

Exhibits


31.1			Rule 13a-14(a) Certification of Chief Executive Officer
31.2			Rule 13a-14(a) Certification of Chief Financial Officer
32			U.S.C. Section 1350 Certifications
101.INS			XBRL Instance Document
101.SCH			XBRL Taxonomy Extension Schema
101.CAL			XBRL Taxonomy Extension Calculation Linkbase
101.DEF			XBRL Taxonomy Extension Definition Linkbase
101.LAB			XBRL Taxonomy Extension Label Linkbase
101.PRE			XBRL Taxonomy Extension Presentation Linkbase
104			Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

Index

PART I – FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

INTELLICHECK, INC.

CONDENSED BALANCE SHEETS (in thousands except share amounts)


	September 30, 2023		December 31, 2022
	(Unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	3,962	$	5,196
Short-term investments	4,948		4,880
Accounts receivable, net of allowance of $43 and $20 at September 30, 2023 and December 31, 2022, respectively	3,898		2,637
Other current assets	577		608
Total current assets	13,385		13,321

PROPERTY AND EQUIPMENT, NET	686		749
GOODWILL	8,102		8,102
INTANGIBLE ASSETS, NET	194		273
OTHER ASSETS	9		8
Total assets	$	22,376	$	22,453

LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES:
Accounts payable	$	572	$	358
Accrued expenses	2,350		2,319
Income taxes payable	—		90
Equity awards liability	40		54
Liability for shares withheld	190		221
Deferred revenue, current portion	2,153		906
Total current liabilities	5,305		3,948

OTHER LIABILITIES:
Deferred revenue, long-term portion	—		1
Total liabilities	5,305		3,949

COMMITMENTS AND CONTINGENCIES (Note 10)

STOCKHOLDERS’ EQUITY:
Preferred stock - $0.01 par value; 30,000 shares authorized; Series A Convertible preferred stock, zero shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	—		—
Common stock - $.001 par value; 40,000,000 shares authorized; 19,299,547 and 18,957,366 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	19		19
Additional paid-in capital	150,537		149,233
Accumulated deficit	(133,485)		(130,748)
Total stockholders’ equity	17,071		18,504

Total liabilities and stockholders’ equity	$	22,376	$	22,453

See accompanying notes to unaudited condensed financial statements.

Index

INTELLICHECK, INC.

CONDENSED STATEMENTS OF OPERATIONS

(In thousands except shares and per share amounts)

(Unaudited)


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022

REVENUES	$	4,760	$	4,012	$	13,730	$	11,415
COST OF REVENUES	(428)		(358)		(1,112)		(1,038)
Gross profit	4,332		3,654		12,618		10,377

OPERATING EXPENSES
Selling, general and administrative	3,597		2,917		11,382		8,985
Research and development	1,550		1,461		4,134		4,682
Total operating expenses	5,147		4,378		15,516		13,667

Loss from operations	(815)		(724)		(2,898)		(3,290)

OTHER INCOME
Interest and other income	179		—		181		—
Total other income	179		—		181		—

Net loss before provision for income taxes	(636)		(724)		(2,717)		(3,290)
Income tax expense	8		—		20		—

Net loss	$	(644)	$	(724)	$	(2,737)	$	(3,290)

PER SHARE INFORMATION
Loss per common share -
Basic/Diluted	$	(0.03)	$	(0.04)	$	(0.14)	$	(0.17)

Weighted average common shares used in computing per share amounts -
Basic/Diluted	19,278,295		18,918,596		19,209,620		18,802,892

See accompanying notes to unaudited condensed financial statements.

Index

INTELLICHECK, INC.

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands except number of shares)

(Unaudited)


	Three months ended September 30, 2023
	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount

BALANCE, June 30, 2023	19,251,920	$	19	$	150,159	$	(132,841)	$	17,337

Stock-based compensation	–	–		381		–		381
Issuance of shares for vested restricted stock grants	47,627	–		–		–		–
Shares forfeited in exchange for withholding taxes	–	–		(3)		–		(3)
Net loss	–	–		–		(644)		(644)
BALANCE, September 30, 2023	19,299,547	$	19	$	150,537	$	(133,485)	$	17,071


	Three months ended September 30, 2022
	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount

BALANCE, June 30, 2022	18,875,580	$	19	$	147,804	$	(129,463)	$	18,360

Stock-based compensation	–	–		696		–		696
Issuance of shares for vested restricted stock grants	54,932	–		–		–		–
Net loss	–	–		–		(724)		(724)
BALANCE, September 30, 2022	18,930,512	$	19	$	148,500	$	(130,187)	$	18,332

See accompanying notes to unaudited condensed financial statements.

Index

INTELLICHECK, INC.

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands except number of shares)

(Unaudited)


	Nine months ended September 30, 2023
	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount

BALANCE, December 31, 2022	18,957,366	$	19	$	149,233	$	(130,748)	$	18,504

Stock-based compensation	–	–		1,361		–		1,361
Issuance of common stock for vested restricted stock units and earned performance stock units	366,901	–		–		–		–
Shares forfeited in exchange for withholding taxes	(24,720)	–		(57)		–		(57)
Net loss	–	–		–		(2,737)		(2,737)
BALANCE, September 30, 2023	19,299,547	$	19	$	150,537	$	(133,485)	$	17,071


	Nine months ended September 30, 2022
	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount

BALANCE, December 31, 2021	18,660,369	$	19	$	146,455	$	(126,897)	$	19,577

Stock-based compensation	–	–		2,045		–		2,045
Issuance of shares for vested restricted stock grants	270,143	–		–		–		–
Net loss	–	–		–		(3,290)		(3,290)
BALANCE, September 30, 2022	18,930,512	$	19	$	148,500	$	(130,187)	$	18,332

See accompanying notes to unaudited condensed financial statements

Inde x

INTELLICHECK, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


	Nine months ended September 30,
	2023		2022

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(2,737)	$	(3,290)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	210		209
Stock-based compensation	1,347		1,768
Allowance for credit losses	23		6
Change in accrued interest and accretion of discount on short-term investments	(154)		—
Changes in assets and liabilities:
(Increase) in accounts receivable	(1,284)		(449)
(Increase) decrease in other current assets and long-term assets	31		176
(Decrease) in accounts payable and accrued expenses	204		(588)
Increase in deferred revenue	1,246		457
Net cash used in operating activities	(1,114)		(1,711)


CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(68)		(165)
Proceeds from maturity of short-term investments	5,000		—
Purchases of short-term investments	(4,914)		—
Net cash provided by (used in) investing activities	18		(165)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds of insurance financing arrangement	49		—
Withholding taxes paid on RSU vesting	(54)		—
Repayment of insurance financing arrangements	(133)		—
Net cash used in financing activities	(138)		—

Net decrease in cash	(1,234)		(1,876)

CASH, beginning of period	5,196		13,651

CASH, end of period	$	3,962	$	11,775

Supplemental disclosures of cash flow information:
Cash paid for interest	$	2	$	—
Cash paid for income taxes	$	78	$	—

See accompanying notes to unaudited condensed financial statements.

Inde x

INTELLICHECK, INC.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

(All dollar amounts are rounded to thousands, except share data)

(Unaudited)

1. NATURE OF BUSINESS

Business

Intellicheck, Inc. (the “Company” or “Intellicheck”) is a prominent technology company engaged in developing, integrating and marketing identity verification solutions to address challenges that include commercial retail and banking fraud prevention. Intellicheck’s products include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices. Intellicheck continues to develop and release innovative products based upon its rich patent portfolio consisting of ten (10) U.S. and one Canadian patents.

Liquidity

For the nine months ended September 30, 2023, the Company incurred a net loss of $(2,737) and used cash in operations of $(1,114). As of September 30, 2023, the Company had cash and cash equivalents of $3,962, short-term investments of $4,948, working capital (defined as current assets minus current liabilities) of $8,080 and an accumulated deficit of $(133,485). Based on the Company’s business plan and cash resources, Intellicheck expects its existing and future resources and revenues generated from operations to satisfy its working capital requirements for at least the next 12 months from the date of filing.

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the unaudited interim financial statements furnished herein include all adjustments necessary for a fair presentation of the Company’s financial position at September 30, 2023, the results of operations, and stockholders’ equity for the three and nine-months ended September 30, 2023 and 2022 and cash flows for the nine months ended September 30, 2023 and 2022. All such adjustments are of a normal and recurring nature. Interim financial statements are prepared on a basis consistent with the Company’s annual financial statements. Results of operations for the three and nine-month periods ended September 30, 2023, are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2023.

The balance sheet as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all of the information and notes required by GAAP for complete financial statements.

References in this Quarterly Report on Form 10-Q to “authoritative guidance” is to the Accounting Standards Codification ("ASC") issued by the Financial Accounting Standards Board (“FASB”).

An adjustment has been made to the Consolidated Balance Sheet and Consolidated Statements of Cash Flows for fiscal year ended October 31, 2019, to reclassify the Value Added Tax (VAT) receivable.

For further information, refer to the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") to measure credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was

Inde x

previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The guidance is effective for smaller reporting companies for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of certain amendments of this guidance must be applied on a modified retrospective basis and the adoption of the remaining amendments must be applied on a prospective basis. The Company concluded that the adoption of this standard, on January 1, 2023, did not have a material impact on its financial statements because of the short-term nature of its outstanding accounts receivable and there have been no significant forward-looking economic conditions identified by the Company that would impact its short-term investments.

Use of Estimates

The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s financial statements and accompanying notes. Significant estimates and assumptions that affect amounts reported in the financial statements include impairment consideration and valuation of goodwill and intangible assets, deferred tax valuation allowances, allowance for credit losses, revenue recognition (including breakage revenue) and the fair value of stock options under the Company’s stock-based compensation plan. Due to the inherent uncertainties involved in making estimates, actual results reported in future periods may be different from those estimates.

Research and Development

Research and development expenses are expensed as incurred and consist primarily of employee-related expenses (such as salaries, taxes, benefits and stock-based compensation), allocated overhead costs and outside services costs related to the development and improvement of the Company's SaaS applications.

Allowance for Credit Losses

Effective January 1, 2023 Intellicheck applied the new standard ASU 2016-13, codified as ASC 326. This impacts how the allowance for doubtful accounts is calculated. Prior to ASC-326, Intellicheck would not recognize bad debt expense until the loss from customer non-payment was probable of occurring. Under the new model, Intellicheck’s allowance for doubtful accounts reflects the Company’s estimate of all expected future losses from its current customer balances. Under the new guidance, the Company has applied a loss rate method which takes historical data as the basis for calculating the allowance amount, along with accounting for other factors like current and forecasted market conditions, and potential future impacts to the industry. In estimating whether accounts receivable will be collected, the Company performs evaluations of customers and continuously monitors collections and payments and estimates an allowance for credit losses based on collections experience to date and any specific collection issues that have been identified. The allowance for credit losses is recorded in the period in which revenue is recorded or when collection risk is identified.

Cash and Cash Equivalents

We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents. Our cash and cash equivalents consist primarily of both cash on deposits with banks, which are maintained with major financial institutions in the United States, and money market funds. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000, however amounts may exceed FDIC insured limits.

Short-term investments

Short-term investments include investments in U.S. treasury notes. Debt investments with original maturities at the date of purchase greater than approximately three months but less than a year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the Company holds are classified as "held-to-maturity". See Note 3 for more detail and a breakdown of the Company's short-term investments.

Inde x

Property and Equipment

Property and equipment are recorded at cost and are depreciated over their estimated useful lives ranging from three to seven years using the straight-line method. See Note 4.

Goodwill

Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, Intangibles - Goodwill and Other, the Company tests goodwill for impairment on an annual basis in the fourth quarter on December 31st, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assesses qualitative factors to determine whether it is necessary to perform step one of the quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decreases in share price.

The Company performed its annual impairment test of goodwill in the fourth quarter for the year ended December 31, 2022. For the nine months ended September 30, 2023 and 2022, the Company determined no triggering events existed and as such no impairment charge was required.

Intangible Assets

Intangible assets include patents, copyrights, and developed technology. The Company amortizes these assets on a straight-line basis over their estimated useful lives, as it represents the pattern of economic benefits consumed. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable in accordance with ASC 360, Property, Plant and Equipment. To determine recoverability of its long-lived assets, the Company evaluates the probability that future undiscounted net cash flows will be less than the carrying amount of the assets. There were no impairment charges recognized during the three and nine-months ended September 30, 2023 and 2022.

Advertising Costs

Advertising costs, which are expensed as incurred, were $470 and $545 for the nine months ended September 30, 2023 and 2022, respectively. Advertising costs were $99 and $155 for the three months ended September 30, 2023 and 2022, respectively. These costs are recorded as a component of selling, general and administrative expenses within the Statements of Operations.

Retirement Plan

The Company has a retirement savings 401(k) plan ("Retirement Plan"). The Retirement Plan permits eligible employees to make voluntary contributions to a trust, up to a maximum of 35% of compensation, subject to certain limitations. The Company has elected to contribute a matching contribution equal to 50% of the first 6% of an eligible employee’s deferral election. The Company’s matching contributions were $85 and $90 for the nine months ended September 30, 2023 and 2022, respectively. The Company’s matching contributions were $31 and $30 for the three months ended September 30, 2023 and 2022, respectively. These costs were recorded as a component of selling, general and administrative expenses within the Statements of Operations.

Shipping Costs

The Company’s shipping and handling costs related to sales are included in cost of revenues for all periods presented. All other shipping and handling costs are included as a component of selling, general and administrative expenses within the Statements of Operations.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial

Inde x

statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The Company has recorded a full valuation allowance for its net deferred tax assets as of September 30, 2023 and December 31, 2022, as it is more likely than not these assets may not be fully realized due to the uncertainty of the realizability of those assets.

Fair Value of Financial Instruments

The Company adheres to the provisions of ASC 820, “Fair Value Measurement” which requires the Company to calculate the fair value of financial instruments and include this additional information in the notes to financial statements when the fair value of those financial instruments is different than the book value. The Company’s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, other current assets, accounts payable and accrued expenses. At September 30, 2023 and December 31, 2022, the carrying value of the Company’s financial instruments approximated fair value, due to their short-term nature.

FASB guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).

The three levels of the fair value hierarchy are as follows:


•Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. The Company's Level 1 assets consisted primarily of cash and cash equivalents as well as short-term investments totaling $8.9 and $10.1 million as of September 30, 2023 and December 31, 2022 respectively.
•Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. The Company had $40 and $54 of Level 2 liabilities as of September 30, 2023 and December 31, 2022 respectively, for the liability-classified stock options. The fair value of these awards were determined by utilizing a Black-Scholes option pricing model.
•Level 3—Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when the fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company had no Level 3 assets or liabilities as of September 30, 2023 and December 31, 2022.

Revenue Recognition and Deferred Revenue

General

Most license fees and services revenue are generated from a combination of fixed-price and per-scan contracts. Under the per-scan revenue model, customers are charged a fee each time the customer scans an identity document, such as a driver’s license, with the Company’s software. Under the fixed-price revenue model customers are charged a fixed monthly fee either per device or physical business location to access the Company’s software. Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration expected to be received in exchange for those goods or services. The Company measures revenue based on the consideration specified in a customer arrangement, and revenue is recognized when the performance obligations in an arrangement are satisfied. A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as, the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as they are performed. Substantially all customer contracts provide that the Company is compensated for services performed to date.

Inde x

The Company has adopted an additional revenue model where customers purchase a predetermined number of transactions for the term of the contract. Revenue for these transactions is recognized on a per transaction basis. The Company estimates the amount of unused transactions at the end of each contract period and recognizes a portion of that revenue as breakage revenue each reporting period. If the Company expects the customer to use all transactions in the specified service period, the Company will recognize the transaction price as revenue in the specified service period as the promised units of service are transferred to the customer. Alternatively, if the Company expects that the customer cannot or will not use all transactions in the specified service period (referred to as “breakage”), the Company will recognize the estimated breakage amount as revenue ratably over the service period in proportion to the revenue that the Company will recognize for actual transactions used by the customer in the service period. Actual results could differ from estimates and as such differences may be material to the financial statements.

Invoicing is based on schedules established in customer contracts. Payment terms are generally established from 30 to 60 days from the invoice date. Product returns are estimated and recorded as a reduction to revenue, however, such amounts have been immaterial.

Nature of goods and services

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

Software as a Service (SaaS)

Software as a service (SaaS) for hosted subscription services requires the Company to provide a stand-ready obligation and allows customers to access a set of data for a predetermined period of time. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the entity’s performance as the entity performs. Accordingly, the revenue should be recognized over time, under the fixed pricing model, based on the usage of the hosted subscription services, which can vary from month to month. Under the per-scan revenue model, the customer requires access to the Company's hosted subscription service but revenue is recognized each time the customer scans an identity document.

Equipment Revenue

Revenue from the sale of equipment is recognized at a point in time. The point in time that the revenue is recognized is when the customer has control of the equipment which is when the customer receives the benefit and the Company’s performance obligation has been satisfied. Depending on the contract terms, that could either be at the time the equipment is shipped or at the time the equipment is received. When sales of equipment occur, we recognize shipping and handling costs with the sales of equipment that are recognized as revenue.

Other Revenue

Other Revenues, which historically have not been material, consist primarily of revenues from other subscription and support services, and extended warranties. The Company’s revenues from other subscription and support services includes jurisdictional updates to certain commercial customers and support services particularly to its Defense ID® customers. These subscriptions require continuing service or post contractual customer support and performance. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. Accordingly, the revenue should be recognized over time based on usage, which can vary from month to month. The revenue is typically based on a formula such as number of locations in a given month multiplied by a fee per location.

Extended warranty revenues are generated when a warranty is provided to the customer separately of other performance obligations when the equipment is sold. As the customer obtains access at a point in time and continues to have access for the remainder of the warranty term, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. The related revenue is recognized ratably over the specified term of the warranty period. The extended warranty is separate to the Company’s standard warranty of usually one year that it receives from its vendor.

Inde x

Disaggregation of revenue

In the following tables, revenue is disaggregated by product and service and the timing of revenue recognition.


	For the Three Months Ended September 30,
	2023		2022
Products and services

Software as a Service (SaaS)	$	4,635	$	3,970
Equipment	106		39
Other	19		3
	$	4,760	$	4,012

Timing of revenue recognition

Products transferred at a point in time	$	125	$	42
Services transferred over time	4,635		3,970
	$	4,760	$	4,012


	For the Nine Months Ended September 30,
	2023		2022
Products and services

Software as a Service (SaaS)	$	13,526	$	11,249
Equipment	152		155
Other	52		11
	$	13,730	$	11,415
Timing of revenue recognition

Products transferred at a point in time	$	204	$	166
Services transferred over time	13,526		11,249
	$	13,730	$	11,415

Contract balances

The current portion of deferred revenue at September 30, 2023, December 31, 2022 and December 31, 2021 was $2,153, $906 and $1,266, respectively, and primarily consists of revenue recognized over time for software license contracts and hosted subscription services. The changes in these balances are related to purchases of a predetermined number of transactions, partially offset by the satisfaction or partial satisfaction of these contracts. Of the December 31, 2022 balance, $224 and $816 were recognized as revenue in the three and nine months ended September 30, 2023, respectively. The noncurrent deferred revenue balances were $0, $1 and $8 as of September 30, 2023, December 31, 2022 and December 31, 2021, respectively.

Accounts Receivable

Accounts Receivable, net of allowance for doubtful accounts, at September 30, 2023, December 31, 2022 and December 31, 2021 was $3,898, $2,637, and $2,192, respectively. The allowance for doubtful accounts at September 30, 2023, December 31, 2022 and December 31, 2021 was $43, $20 and $3, respectively.

Inde x

Transaction price allocated to the remaining performance obligations

The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period:


	Remainder 2023		2024		2025		Total

Software as a Service (SaaS)	$	427	$	1,721	$	—	$	2,148
Other	5		—		—		5
	$	432	$	1,721	$	—	$	2,153

All consideration from contracts with customers is included in the amounts presented above.

Business Concentrations and Credit Risk

Financial instruments, which subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents. The Company maintains cash with two financial institutions. The Company performs periodic evaluations of the relative credit standing of these institutions.

The Company’s sales are principally made to large retail customers, financial institutions concentrated in the United States of America and to U.S. government entities. The Company performs ongoing credit evaluations, generally does not require collateral, and establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of customers, historical trends, and other market and economic information.

During the nine-month period ended September 30, 2023, the Company made sales to three customers that accounted for approximately 49% of total revenues, 21%, 14% and 14%, respectively. The revenue was primarily associated with commercial identity sales customers. These three customers, in addition with one other customer, represented 58% of total accounts receivable at September 30, 2023, 38%, 3%, 5%, and 12% respectively. During the nine-month period ended September 30, 2022, the Company made sales to three customers that accounted for approximately 52% of total revenues, 22%, 17% and 13%, respectively. These three customers, in addition with two other customers, represented 70% of total accounts receivable at September 30, 2022, 32%, 7%, 1%, 11% and 19%, respectively. The revenue on those five customers was also associated with commercial identity sales customers.

Net Loss Per Share

Basic net loss per share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted average number of shares of common stock and potentially dilutive common stock equivalents outstanding during the period. The dilutive effect of outstanding options, warrants, and restricted stock is reflected in diluted earnings

Inde x

per share by application of the treasury stock method. The calculation of diluted net loss per share excludes all anti-dilutive shares. In periods of a net loss, all common stock equivalents are considered anti-dilutive.


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Numerator:

Net Loss	$	(644)	$	(724)	$	(2,737)	$	(3,290)

Denominator:
Weighted average common shares –
Basic/Diluted	19,278,295		18,918,596		19,209,620		18,802,892

Net Loss per share –
Basic/Diluted	$	(0.03)	$	(0.04)	$	(0.14)	$	(0.17)

The following table summarizes the common stock equivalents excluded from loss per diluted share because their effect would be anti-dilutive:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Stock options	1,230,905	1,164,676	1,230,905	1,164,676
Restricted stock	73,182	203,492	73,182	203,492
Performance stock units	—	177,688	—	177,688
	1,304,087	1,545,856	1,304,087	1,545,856

Reclassification of Prior Year Presentation

Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on net earnings. An adjustment has been made to the Condensed Statements of Cash Flows to reclassify the allowance for credit losses. This change in classification does not affect previously reported cash flows from operating activities in the Condensed Statements of Cash Flows.

3. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

Short-term investments include investments in U.S. treasury notes. Short-term investments with original maturities of approximately three months or less from the date of purchase are classified within cash and cash equivalents. Debt investments with original maturities at the date of purchase greater than approximately three months but less than one year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the company holds are classified as "held-to-maturity". The Company has accounted for and disclosed the purchase of its short-term investments in accordance with ASC 320 ("Investments - Debt Securities"). The following table summarizes the fair value of cash and cash equivalents, and short-term investments as well as any gross unrealized holding gains and losses as of September 30, 2023. Due to the nature of these assets and the short-term nature of

Inde x

the U.S. treasury notes being held to maturity, both these cash and cash equivalents and short-term investments fall under the Level 1 fair value hierarchy as referenced in Note 2.


	As of September 30, 2023
	Amortized cost		Gross unrealized holding gains		Gross unrealized holding losses		Estimated fair value

Cash and cash equivalents	$	3,962	$	—	$	—	$	3,962
U.S. treasury notes (1)	4,948		—		(5)		4,943
Total cash, cash equivalents and short-term investments	$	8,910	$	—	$	(5)	$	8,905

(1) These U.S. treasury notes are classified as "held-to-maturity" as they were purchased in August 2023 and mature in December 2023. Since these securities are intended to be held until maturity and mature in less than a year from their purchase date, any unrealized gains or losses are not realized until their maturity date and the amortized cost of these securities can be found on this Form 10-Q's balance sheet under Current Assets - "Short-term investments". Any coupon payments from these short-term investments fall under "Interest and other (expense) income" within the Company's Statement of Operations.

The Company did not hold any securities that were in an unrealized loss position for more than 12 months as of September 30, 2023 and 2022. There were no material realized gains or losses on these specific short-term investments during the quarters ended September 30, 2023 and September 30, 2022. The Company recognized $120 in realized gains on short-term investments that matured within the quarter during the quarter ended September 30, 2023.

4. PROPERTY AND EQUIPMENT

Property and equipment is summarized as follows:


	September 30, 2023		December 31, 2022
Computer equipment and software	$	1,865	$	1,796
Furniture and fixtures	139		139
Office equipment	614		614
	2,618		2,549
Less – Accumulated depreciation	(1,932)		(1,800)
	$	686	$	749

Depreciation expense for the nine months ended September 30, 2023 and 2022 amounted to $131 respectively. Depreciation expense for the three months ended September 30, 2023 and 2022 amounted to $45 and $44, respectively.

5. INTANGIBLE ASSETS

The changes in the carrying amount of intangible assets for the nine months ended September 30, 2023 were as follows:


Net balance at December 31, 2022	$	273
Deduction: Amortization expense	(79)
Net balance at September 30, 2023	$	194

Inde x

The following tables set forth the components of intangible assets as of September 30, 2023 and December 31, 2022:


		As of September 30, 2023
	Estimated Useful Life	Adjusted Carrying Amount		Accumulated Amortization		Net

Patents and copyrights	2-17 years	$	375	$	(294)	$	81
Developed technology	5 years	400		(287)		113
		$	775	$	(581)	$	194


		As of December 31, 2022
	Estimated Useful Life	Adjusted Carrying Amount		Accumulated Amortization		Net

Patents and copyrights	2-17 years	$	375	$	(275)	$	100
Developed technology	5 years	400		(227)		173
		$	775	$	(502)	$	273

The following summarizes amortization of intangible assets included in the accompanying statements of operations:


	Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of sales	$	24	$	23	$	71	$	71
General and administrative	3		3		8		8
	$	27	$	26	$	79	$	79

6. DEBT

Revolving Line of Credit

On February 6, 2019, the Company entered into a revolving credit facility with Citi Personal Wealth Management that allows for borrowings up to the lesser of (i) $2,000 or (ii) the collateralized balance in the Company’s existing fixed income investment account with Citi Personal Wealth Management subject to certain limitations. The facility bears interest at a rate consistent with Citi Personal Wealth Management’s Base Rate (8.50% and 7.50% at September 30, 2023 and December 31, 2022, respectively) minus 2%. Interest is payable monthly and as of September 30, 2023 and December 31, 2022, there were no amounts outstanding and unused availability under this facility was $2,000. The Company is not subject to any financial covenants related to this revolving line of credit. This line will remain open as long as the Company keeps a depository relationship with the financial institution.

Insurance Financing Arrangement

On February 2023, the Company entered into a financing arrangement related to insurance premiums totaling $49 with an interest rate of 9.47%. The monthly loan payments of $5 are to be paid to IPFS of New York, LLC over a period of 11 months. As of September 30, 2023, the Company had $14 in remaining commitments related to this financing arrangement which is included within the "Accrued expenses" line within the balance sheet as of September 30, 2023. The Company is not subject to any financial covenants related to this insurance financing arrangement.

Inde x

7. ACCRUED EXPENSES

Accrued expenses are comprised of the following:


	September 30, 2023		December 31, 2022
Professional fees	$	110	$	259
Payroll and related	1,536		1,040
Incentive bonuses	617		846
Other	87		174
	$	2,350	$	2,319

The Company incurs costs related to employee severance and records a liability for these costs when it is probable that employees will be entitled to termination benefits and the amounts can be reasonably estimated. The liability related to these actions is included in the "Payroll and related" line item within the accrued expenses line on the Condensed Balance Sheets.

8. INCOME TAXES

Our available net operating loss (“NOL”) as of December 31, 2022 was approximately $20.8 million, of which $10.9 million expires between 2035 and 2037. In accordance with the Tax Cuts and Jobs Act of 2017 (the "Tax Act"), U.S. NOLs arising in a tax year ending after 2017 will not expire.

ASC 740 requires evaluation of uncertain tax positions and as of September 30, 2023, the Company has no material uncertain tax positions.

The Company’s interim income tax provision consists of U.S. federal and state income taxes based on the estimated annual effective tax rate that the Company expects for the full year together with the tax effect of discrete items. Each quarter the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as necessary. As of September 30, 2023, the Company was in a pre-tax loss position, and is anticipated to remain so throughout the year. The effective tax rate for the three and nine months ended September 30, 2023 is different from the tax benefit that would result from applying the statutory tax rates primarily due to the recognition of valuation allowances.

9. STOCKHOLDERS' EQUITY

Stock-based Compensation

To retain and attract qualified personnel necessary for the success of the Company, the Company adopted the 2015 Omnibus Incentive Plan (the “Plan”) covering up to 5,236,000 of the Company’s common shares, pursuant to which officers, directors, key employees and consultants to the Company are eligible to receive incentive stock options, nonqualified stock options and restricted stock units. All the equity compensation plans prior to Company’s 2015 Omnibus Incentive Plan have been closed. The Compensation Committee of the Board of Directors administers this Plan and determines the terms and conditions of stock options granted, including the exercise price. This Plan generally provides that all stock options will expire within ten years of the date of grant. Incentive stock options granted under this Plan must be granted at an exercise price that is not less than the fair market value per share at the date of the grant and the exercise price must not be less than 110% of the fair market value per share at the date of the grant for grants to persons owning more than 10% of the voting stock of the Company. This Plan also entitles non-employee directors to receive grants of non-qualified stock options as approved by the Board of Directors.

The Company accounts for the issuance of stock-based awards to employees in accordance with ASC Topic 718, "Compensation - Stock Compensation", which requires that the cost resulting from all stock-based compensation payment transactions be recognized in the financial statements. This pronouncement establishes fair value as the measurement objective in accounting for stock-based compensation payment arrangements and requires all companies to apply a fair

Inde x

value based measurement method in accounting for all stock-based compensation payment transactions with employees. All stock-based compensation is included in operating expenses as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Compensation cost recognized:
Selling, general & administrative	$	301	$	561	$	1,125	$	1,270
Research & development	41		168		222		498
	$	342	$	729	$	1,347	$	1,768

Stock Options

The Company uses the Black-Scholes option pricing model to value the options on the grant date. The table below presents the weighted average expected life of the stock options in years. The Company uses the simplified method for all restricted stock units and stock options to estimate the expected life of the option and assumes that stock options will be exercised evenly over the period from vesting until the awards expire. Volatility is determined using changes in historical stock prices. The interest rate for periods within the expected life of the award is based on U.S. Treasury yield curve in effect on the grant date. Options, generally, vest from one year to four years. The compensation expense is recognized over the requisite service period on a straight-line basis, reduced by forfeitures as they occur.

Certain option awards are classified as liability awards. The fair value of these awards are determined at each reporting period utilizing a Black-Scholes option pricing model, and the associated compensation expense (credit) for the reporting period is recorded. The Company decreased stock-based compensation expense by approximately $(39) and decreased by approximately $(14) for the three and nine-months ended September 30, 2023, respectively, as a result of the change in fair value of these awards. The Company increased and decreased stock-based compensation expense by approximately $33 and $(277) for the three and nine-months ended September 30, 2022, respectively, as a result of the change in fair value of these awards.

Stock option activity under the 2015 Plan during the period indicated below is as follows:


	Number of Shares Subject to Issuance	Weighted- average Exercise Price		Weighted- average Remaining Contractual Term	Aggregate Intrinsic Value

Outstanding at December 31, 2022	1,120,244	$	3.68	3.50 years	$	84
Granted	627,507	2.91		–	–
Forfeited, cancelled, or expired	(516,846)	3.89		–	–
Outstanding at September 30, 2023	1,230,905	$	2.33	3.08 years	$	135

Exercisable at September 30, 2023	593,494	$	3.69	2.10 years	$	73

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on September 30, 2023. This amount changes based upon the fair market value of the Company’s stock.

Inde x

Restricted Stock Units

The Company issues restricted stock units (“RSUs”) which are equity-based instruments that may be settled in shares of common stock of the Company. During the nine months ended September 30, 2023, the Company issued RSUs to certain directors as compensation. RSU agreements can vest immediately or with the passage of time. The vesting of all RSUs is contingent on continued board and employment services.

The compensation expense incurred by the Company for RSUs is based on the closing market price of the Company’s common stock on the date of grant, is amortized on a straight-line basis over the requisite service period and charged to operating expenses with a corresponding increase to additional paid-in capital, reduced by forfeitures when they occur.

Restricted stock unit activity during the period indicated below is as follows:


	Number of Shares	Weighted Average Grant Date Fair Value

Outstanding at December 31, 2022	214,892	$	8.43
Granted	207,306	2.43
Forfeited or surrendered	(70,959)	10.04
Vested and settled in shares	(278,057)	4.42

Outstanding at September 30, 2023	73,182	$	5.11

Performance Stock Units

On August 7, 2020, the Company issued 265,942 performance stock units (PSUs) to its officers and certain employees as compensation ("PSU Plan"). 50% of the PSUs were to vest based on the Company’s market price and 50% were to vest based on the Company’s Adjusted EBITDA. Both the conditions were to occur over a specified time frame and were contingent on continued employment services.

On November 4, 2021, the Company amended its PSU Plan so that 100% of the PSUs vest based on the Company’s market price as the sole vesting criteria. As a result of this amendment, the Adjusted EBITDA performance metric is no longer a vesting criterion.

The fair value of these awards with a market condition was estimated, at the date of grant, using the Monte Carlo Simulation model with compensation expense being determined on the closing market price of the Company’s common stock on the date of grant and is amortized ratably on a straight-line basis over the requisite service period. With the amendment mentioned above such that the Company's market price is the sole vesting criteria for these awards, compensation expense is charged to operating expenses with a corresponding increase to additional paid-in capital and is not reversed if the vesting criteria is not met. As of September 30, 2023, there were no outstanding PSUs.


	Number of Shares	Weighted Average Grant Date Fair Value

Outstanding at December 31, 2022	177,688	$	7.91
Forfeited	(88,844)	7.91
Vested and settled in shares	(88,844)	7.91
Outstanding at September 30, 2023	—	$	7.91

Inde x

As of September 30, 2023, there was approximately $1,028 of total unrecognized compensation costs, related to all unvested stock options and RSUs. These costs are expected to be recognized as compensation expense over a weighted-average period of approximately 2.01 years.

The Company had 1,175,031 shares available for future grants under the Company's equity compensation plans at September 30, 2023.

10. COMMITMENTS AND CONTINGENCIES

The Company is not aware of any infringement by the Company’s products or technology on the proprietary rights of others.

The Company is not currently involved in any legal or regulatory proceeding, or arbitration, the outcome of which is expected to have a material effect on its business.

As of September 30, 2023, we are reviewing our historical state sales and use tax liabilities. The Company is subject to sales and use taxes in jurisdictions where it has economic nexus. These reviews, in addition to our conversations with state taxing authorities, may lead to adjustments to the reporting of transactional taxes. We are currently assessing the outcomes that may result from these reviews, which may lead to adjustments to our taxes or net operating losses with respect to the years under review, as well as the current period. We may be subject to additional accruals for the expected outcome of these sales and use tax matters.

Inde x

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (All dollar amounts are rounded to thousands, except shares and per share data)

Forward Looking Statements

This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, particularly statements anticipating future growth in revenues, loss from operations and cash flow. Words such as “anticipates,” “estimates,” “expects,” “projects,” “intends,” “plans,” “believes” and words and terms of similar substance used in connection with any discussion of future operating or financial performance identify forward-looking statements. These forward-looking statements are based on management’s current expectations and beliefs about future events. As with any projection or forecast, they are inherently susceptible to uncertainty and changes in circumstances, and the Company is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of such changes, new information, subsequent events or otherwise. References made in this Quarterly Report on Form 10-Q to “we,” “our,” “us,” “Intellicheck,” or the “Company,” refer to Intellicheck, Inc.

The following discussion and analysis of our financial condition and results of operations constitutes management’s review of the factors that affected our financial and operating performance for the three and nine-month periods ended September 30, 2023. This discussion should be read in conjunction with the financial statements and notes thereto contained elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2022.

Overview

We are a prominent technology company engaged in developing, integrating and marketing identity verification solutions to address challenges that include commercial retail and banking fraud prevention. Our products include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Critical Accounting Policies and the Use of Estimates

The preparation of our financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Significant estimates and assumptions that affect amounts reported in the financial statements include impairment consideration and valuation of goodwill and intangible assets, deferred tax valuation allowances, allowance for credit losses, revenue recognition (including breakage revenue), and the fair value of stock options under our stock-based compensation plans. Due to the inherent uncertainties involved in making estimates, actual results reported in future periods may be different from those estimates.

We believe that there are several accounting policies that are critical to understanding our historical and future performance, as these policies affect the reported amounts of revenue and the more significant areas involving management’s judgments and estimates. These significant accounting policies relate to revenue recognition, stock-based compensation, deferred taxes, goodwill and intangible asset valuation and impairment, and commitments and contingencies. These policies and our procedures related to these policies are summarized below and described in further detail in the Notes to Financial Statements.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments to measure credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The guidance is effective for smaller reporting companies for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of certain amendments of this guidance must be applied on a modified retrospective basis and the adoption of the remaining amendments must be applied on a prospective basis. The Company concluded that the adoption of this standard did not have a material impact on its financial statements because of the short-term nature of it's outstanding accounts receivable and there have been no significant forward-looking economic conditions identified by the Company that would impact its short-term investments.

Inde x

Goodwill

The excess of the purchase consideration over the fair value of the assets of acquired businesses is considered goodwill. Under authoritative guidance, goodwill is not amortized, but rather it is periodically reviewed for impairment. We had goodwill of $8,102 as of September 30, 2023.

For the year ended December 31, 2022, the Company performed its annual impairment test of goodwill in the fourth quarter of the fiscal year. Under authoritative guidance, the Company can use industry and Company specific qualitative factors to determine whether it is more likely than not that impairment exists before performing step one of the quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.

We determined that no events occurred or circumstances changed during the nine months ended September 30, 2023 that would more likely than not reduce the fair value of the Company below its carrying amounts. We will, however, continue to monitor our stock price and operations for any potential indicators of impairment. We will conduct the 2023 annual test for goodwill impairment in the fourth quarter, or at such time where an indicator of impairment appears to exist.

Intangible Assets

Our intangible assets consist of patents and a software license. We determined that no events occurred, or circumstances changed during the nine months ended September 30, 2023 that would more likely than not reduce our intangible assets below our carrying amounts. We will, however, continue to monitor any potential indicators of impairment. See Note 5, “Intangible Assets,” in the Notes to Financial Statements for details on the Company’s intangible assets.

Revenue Recognition and Deferred Revenue

SaaS fees and service revenues are generated from a combination of fixed-price and per-scan contracts. Under the per-scan revenue model, customers are charged a fee each time the customer scans an identity document, such as a driver’s license, with our software. Under the fixed-price revenue model customers are charged a fixed monthly fee either per device or physical business location to access our software. In certain instances, customization services are determined to be essential to the functionality of the delivered software. Under Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers,” revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration expected to be received in exchange for those goods or services. We measure revenue based on the consideration specified in a customer arrangement, and revenue is recognized when the performance obligations in an arrangement are satisfied. The Company adopted an additional revenue model where customers purchase a predetermined number of transactions for the term of the contract, where revenue for these transactions is recognized on a per transaction basis. The Company estimates the number of transactions that will be unused by the end of each contract period and recognized a portion of that revenue as breakage revenue each reporting period. Reference Note 2, “Significant Accounting Policies,” in the Notes to Financial Statements for additional details on the Company’s recognized and deferred revenue.

Stock-Based Compensation

We account for the issuance of stock-based compensation awards to employees in accordance with ASC 718, “Compensation – Stock Compensation”, which requires that the cost resulting from all stock-based compensation payment transactions be recognized in the financial statements. This pronouncement establishes fair value as the measurement objective in accounting for stock-based compensation payment arrangements and requires all companies to apply a fair value-based measurement method in accounting for all stock-based compensation payment transactions with employees. Reference Note 9, “Stockholders' Equity,” in the Notes to Financial Statements for details on the Company’s stock-based compensation plans.

Inde x

Deferred Income Taxes

Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. We have recorded a full valuation allowance for our net deferred tax assets as of September 30, 2023, due to the uncertainty of our ability to realize those assets. Reference Note 8, “Income Taxes,” in the Notes to Financial Statements for details on the Company’s income taxes.

Commitments and Contingencies

We are not currently involved in any legal or regulatory proceeding, or arbitration, the outcome of which is expected to have a material adverse effect on our business.

The above listing is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by generally accepted accounting principles, with no need for management’s judgment in their application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result.

Results of Operations

(All dollar amounts are rounded to thousands, except shares and per share data)

COMPARISON OF THE THREE MONTHS ENDED SEPTEMBER 30, 2023

TO THE THREE MONTHS ENDED SEPTEMBER 30, 2022

Revenues for the three months ended September 30, 2023 increased $748, or 19%, to approximately $4,760 compared to $4,012 for the same period of 2022. The increase in revenues is primarily the result of higher SaaS revenue growth for the current period. SaaS revenue, which consists of software licensed as a service on a subscription basis, increased $665 or 17% to $4,635 for the three months ended September 30, 2023 compared to $3,970 for the same period of 2022.

Gross profit increased $678, or 19%, to $4,332 for three months ended September 30, 2023 from $3,654 for the same period of 2022. Our gross profit, as a percentage of revenues, was 91% for the three months ended September 30, 2023 and 2022, respectively.

Operating expenses, which consist of selling, general and administrative and research and development expenses, increased $769, or 18%, to $5,147 for the three months ended September 30, 2023 compared to $4,378 for the same period of 2022. This increase was primarily driven by higher general and administrative costs, specifically headcount-related expenses tied to non-restructuring severance expenses, as well as higher accounting and professional fees.

As a result of the factors noted above, the Company had a net loss of $(644) for the three months ended September 30, 2023 as compared to a net loss of $(724) for the three months ended September 30, 2022.

COMPARISON OF THE NINE MONTHS ENDED SEPTEMBER 30, 2023

TO THE NINE MONTHS ENDED SEPTEMBER 30, 2022

Revenues for the nine months ended September 30, 2023 increased $2,315, or 20%, to $13,730 compared to $11,415 for the same period of 2022. The increase in revenues is primarily the result of higher SaaS revenue growth for the current period. SaaS revenue, which consists of software licensed as a service on a subscription basis, increased $2,277 or 20% to $13,526 for the nine months ended September 30, 2023 compared to $11,249 for the same period of 2022.

Inde x

Gross profit increased $2,241, or 22%, to $12,618 for nine months ended September 30, 2023 from $10,377 for the same period of 2022. Our gross profit, as a percentage of revenues, was 92% and 91% for the nine months ended September 30, 2023 and 2022, respectively.

Operating expenses, which consist of selling, general and administrative and research and development expenses, increased $1,849, or 14%, to $15,516 for the nine months ended September 30, 2023 compared to $13,667 for the same period of 2022. This increase was primarily driven by higher general and administrative costs, specifically headcount-related expenses tied to non-restructuring severance expenses, as well as higher accounting and professional fees.

As a result of the factors noted above, the Company had a net loss of $(2,737) for the nine months ended September 30, 2023 as compared to a net loss of $(3,290) for the nine months ended September 30, 2022.

Liquidity and Capital Resources

As of September 30, 2023, we had cash and cash equivalents of $3,962, short-term investments of $4,948, working capital (defined as current assets minus current liabilities) of $8,080, total assets of $22,376 and stockholders’ equity of $17,071.

During the nine months ended September 30, 2023, we used net cash of $(1,114) in operating activities as compared to net cash of $(1,711) used in the nine months ended September 30, 2022. Cash provided by investing activities was $18 for the nine months ended September 30, 2023 compared to cash used in investing activities of $(165) for the nine months ended September 30, 2022. Cash used in financing activities was $(138) for the nine months ended September 30, 2023.

We currently anticipate that our available cash, expected cash from operations and availability under the revolving line of credit, will be sufficient to meet our anticipated working capital and capital expenditure requirements for at least the next 12 months from the date of filing. Reference Note 6, “Debt,” in the Notes to Financial Statements for details on the Company’s revolving line of credit.

We keep the option open to raise additional funds to respond to business contingencies which may include the need to fund more rapid expansion, fund additional marketing expenditures, develop new markets for our technology, enhance our operating infrastructure, respond to competitive pressures, or acquire complementary businesses or necessary technologies. There can be no assurance that we will be able to secure the additional funds when needed or obtain such on terms satisfactory to us, if at all.

The specific terms of any future offering, including the prices and use of proceeds, will be determined at the time of any such offering and will be described in detail in a prospectus supplement which will be filed with the SEC at the time of the offering.

We are not currently involved in any legal or regulatory proceeding, or arbitration, the outcome of which is expected to have a material effect on our business.

Net Operating Loss Carry Forwards

Our available net operating loss ("NOL") as of December 31, 2022 was approximately $20.8 million, of which $10.9 million expires between 2035 and 2037. In accordance with the Tax Cuts and Jobs Act of 2017 (the "Tax Act"), U.S. NOLs arising in a tax year ending after 2017 will not expire, however will be limited to 80% of each subsequent year's net income.

Adjusted EBITDA and Use of a Non-GAAP Measure

We use Adjusted EBITDA as a non-GAAP financial performance measurement. Adjusted EBITDA is calculated by adjusting net loss for certain reductions such as interest and other income (expense) and certain addbacks such as non-restructuring severance expenses, provisions for income taxes, depreciation, amortization and stock-based compensation expense. Adjusted EBITDA is provided to investors to supplement the results of operations reported in accordance with GAAP. Management believes that Adjusted EBITDA provides an additional tool for investors to use in comparing our financial results with other companies that also use Adjusted EBITDA in their communications to investors. By excluding non-cash charges such as impairments of long-lived assets and goodwill, amortization, depreciation and stock-based

Inde x

compensation, as well as non-operating charges for interest and provisions for income taxes, investors can evaluate our operations and can compare the results on a more consistent basis to the results of other companies. We have included any severance-related expenses for terminated positions that will not be replaced as "non-restructuring severance expenses" within Adjusted EBITDA. In addition, Adjusted EBITDA is one of the primary measures management uses to monitor and evaluate financial and operating results.

We consider Adjusted EBITDA to be an important indicator of our operational strength and performance of our business and a useful measure of our historical operating trends. However, there are significant limitations to the use of Adjusted EBITDA since it excludes non-restructuring severance expenses, provisions for income taxes, interest and other (expense) income, impairments of long-lived assets and goodwill, stock-based compensation expense, all of which impact our profitability, as well as depreciation and amortization related to the use of long-term assets which benefit multiple periods. We believe that these limitations are compensated by providing Adjusted EBITDA only with GAAP net loss and clearly identifying the difference between the two measures. Consequently, Adjusted EBITDA should not be considered in isolation or as a substitute for net loss presented in accordance with GAAP. Adjusted EBITDA as defined by us may not be comparable with similarly named measures provided by other companies.

The reconciliation of GAAP net loss to Non-GAAP Adjusted EBITDA is as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022

Net loss	$	(644)	$	(724)	$	(2,737)	$	(3,290)
Reconciling items:
Non-restructuring severance expenses	131		—		548		—
Provision for income taxes	8		—		20		—
Interest and other expense (income)	(179)		—		(181)		—
Depreciation and amortization	71		70		210		209
Stock-based compensation including liability classified awards	342		729		1,347		1,768

Adjusted EBITDA	$	(271)	$	75	$	(793)	$	(1,313)

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet financing arrangements and have not established any special purpose entities. We have not guaranteed any debt or commitments of other entities or entered into any options on non-financial assets.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable to smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of September 30, 2023 based on the guidelines established in the "Internal Control—Integrated Framework" (2013 framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on its assessment, management concluded that the Company's internal control over financial reporting was effective as of September 30, 2023.

Limitations on Effectiveness of Controls

Inde x

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all controls systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving its objectives.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2023 that has materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II - Other Information

Item 1. LEGAL PROCEEDINGS

None.

Item 1A. Risk Factors

In addition to the risk factor set forth below and the other information set forth in this report, investors should carefully consider the factors discussed under Part I, Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2022 (the “2022 Annual Report”). These factors could have a material adverse effect on our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by the forward-looking statements contained in this report. Except as disclosed below, there have been no material changes to the risk factors described in Part I, Item 1A, “Risk Factors,” included in our 2022 Annual Report.

The Company's cash and cash equivalents could be adversely affected by bank failures or other events affecting financial institutions and could adversely affect our liquidity and financial performance.

We regularly maintain domestic cash deposits in Federal Deposit Insurance Corporation (“FDIC”) insured banks, in amounts which exceed the FDIC insurance limits. The failure or rumored failure of a bank, or events involving limited liquidity, defaults, non-performance, bankruptcy, receivership or other adverse developments in the financial or credit markets impacting financial institutions, may lead to disruptions in access to our bank deposits. These disruptions could impact our liquidity and financial performance. There can be no assurance that our deposits in excess of the FDIC or other comparable insurance limits will be backstopped by the U.S. government, or that any bank or financial institution with which we do business will be able to obtain needed liquidity from other banks, government institutions or by acquisition in the event of a failure or liquidity crisis. As such, those funds in bank deposit accounts in excess of the standard FDIC insurance limits are uninsured and subject to the risk of bank failure.

Currently, we have full access to all funds in deposit accounts or other money management arrangements. The failure of any bank in which we deposit our funds could reduce the amount of cash we have available for our operations or delay our ability to access such funds. In the event of such failure, we may experience delays or other issues in meeting our financial obligations, our ability to access our cash and cash equivalents may be threatened and could have a material adverse effect on our business and financial condition.

Future adverse developments with respect to specific financial institutions or the broader financial services industry may also lead to market-wide liquidity shortages.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

Item 3. DEFAULTS UPON SENIOR SECURITIES

None

Inde x

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION

None

Item 6. EXHIBITS

(a)The following exhibits are filed as part of the Quarterly Report on Form 10-Q:


Exhibit No.						Description

31.1						Rule 13a-14(a) Certification of Chief Executive Officer
31.2						Rule 13a-14(a) Certification of Chief Financial Officer
32						18 U.S.C. Section 1350 Certifications
101.INS						XBRL Instance Document
101.SCH						XBRL Taxonomy Extension Schema
101.CAL						XBRL Taxonomy Extension Calculation Linkbase
101.DEF						XBRL Taxonomy Extension Definition Linkbase
101.LAB						XBRL Taxonomy Extension Label Linkbase
101.PRE						XBRL Taxonomy Extension Presentation Linkbase
104						Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

Inde x

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date:	November 14, 2023	INTELLICHECK, INC.

		By:	/s/ Bryan Lewis
			Bryan Lewis
			President and Chief Executive Officer
			(Principal Executive Officer)

		By:	/s/ Jeffrey Ishmael
			Jeffrey Ishmael
			Chief Financial Officer and Chief Operating Officer

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bryan Lewis, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Intellicheck, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15I and 15d-15I) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.


Date:	November 14, 2023	/s/ Bryan Lewis
		Name:	Bryan Lewis
		Title:	President and Chief Executive Officer
			(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jeffrey Ishmael, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Intellicheck, Inc.;

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.


Date:	November 14, 2023	/s/Jeffrey Ishmael
		Name:	Jeffrey Ishmael
		Title:	Chief Financial Officer and Chief Operating Officer

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Intellicheck, Inc. (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the period ended June 30, 2023 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated:	November 14, 2023	/s/ Bryan Lewis
		Name:	Bryan Lewis
		Title:	President and Chief Executive Officer
			(Principal Executive Officer)
Dated:	November 14, 2023	/s/ Jeffrey Ishmael
		Name:	Jeffrey Ishmael
		Title:	Chief Financial Officer and Chief Operating Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2023	Nov. 14, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-15465
Entity Registrant Name	Intellicheck, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-3234779
Entity Address, Address Line One	200 Broadhollow Road
Entity Address, Address Line Two	Suite 207
Entity Address, City or Town	Melville
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11747
City Area Code	(516)
Local Phone Number	992-1900
Title of 12(b) Security	Common stock, $0.001 par value per share
Trading Symbol	IDN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		19,354,335
Amendment Flag	false
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001040896

CONDENSED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 3,962	$ 5,196
Short-term investments	4,948	4,880
Accounts receivable, net of allowance of $43 and $20 at September 30, 2023 and December 31, 2022, respectively	3,898	2,637
Other current assets	577	608
Total current assets	13,385	13,321
PROPERTY AND EQUIPMENT, NET	686	749
GOODWILL	8,102	8,102
INTANGIBLE ASSETS, NET	194	273
OTHER ASSETS	9	8
Total assets	22,376	22,453
CURRENT LIABILITIES:
Accounts payable	572	358
Accrued expenses	2,350	2,319
Income taxes payable	0	90
Equity awards liability	40	54
Liability for shares withheld	190	221
Deferred revenue, current portion	2,153	906
Total current liabilities	5,305	3,948
OTHER LIABILITIES:
Deferred revenue, long-term portion	0	1
Total liabilities	5,305	3,949
COMMITMENTS AND CONTINGENCIES (Note 10)
STOCKHOLDERS’ EQUITY:
Preferred stock - $0.01 par value; 30,000 shares authorized; Series A Convertible preferred stock, zero shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	0	0
Common stock - $.001 par value; 40,000,000 shares authorized; 19,299,547 and 18,957,366 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	19	19
Additional paid-in capital	150,537	149,233
Accumulated deficit	(133,485)	(130,748)
Total stockholders’ equity	17,071	18,504
Total liabilities and stockholders’ equity	$ 22,376	$ 22,453

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 43	$ 20
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	30,000	30,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	19,299,547	18,957,366
Common stock, shares outstanding (in shares)	19,299,547	18,957,366

CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
REVENUES	$ 4,760	$ 4,012	$ 13,730	$ 11,415
COST OF REVENUES	(428)	(358)	(1,112)	(1,038)
Gross profit	4,332	3,654	12,618	10,377
OPERATING EXPENSES
Selling, general and administrative	3,597	2,917	11,382	8,985
Research and development	1,550	1,461	4,134	4,682
Total operating expenses	5,147	4,378	15,516	13,667
Loss from operations	(815)	(724)	(2,898)	(3,290)
OTHER INCOME
Interest and other income	179	0	181	0
Total other income	179	0	181	0
Net loss before provision for income taxes	(636)	(724)	(2,717)	(3,290)
Income tax expense	8	0	20	0
Net loss	$ (644)	$ (724)	$ (2,737)	$ (3,290)
Loss per common share -
Basic (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.14)	$ (0.17)
Diluted (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.14)	$ (0.17)
Weighted average common shares used in computing per share amounts -
Basic (in shares)	19,278,295	18,918,596	19,209,620	18,802,892
Diluted (in shares)	19,278,295	18,918,596	19,209,620	18,802,892

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		18,660,369
Beginning balance at Dec. 31, 2021	$ 19,577	$ 19	$ 146,455	$ (126,897)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,045		2,045
Issuance of shares for vested restricted stock grants (in shares)		270,143
Net loss	(3,290)			(3,290)
Ending balance (in shares) at Sep. 30, 2022		18,930,512
Ending balance at Sep. 30, 2022	18,332	$ 19	148,500	(130,187)
Beginning balance (in shares) at Jun. 30, 2022		18,875,580
Beginning balance at Jun. 30, 2022	18,360	$ 19	147,804	(129,463)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	696		696
Issuance of shares for vested restricted stock grants (in shares)		54,932
Net loss	(724)			(724)
Ending balance (in shares) at Sep. 30, 2022		18,930,512
Ending balance at Sep. 30, 2022	18,332	$ 19	148,500	(130,187)
Beginning balance (in shares) at Dec. 31, 2022		18,957,366
Beginning balance at Dec. 31, 2022	18,504	$ 19	149,233	(130,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,361		1,361
Issuance of common stock for vested restricted stock units and earned performance stock units (in shares)		366,901
Shares forfeited in exchange for withholding taxes (in shares)		(24,720)
Shares forfeited in exchange for withholding taxes	(57)		(57)
Net loss	(2,737)			(2,737)
Ending balance (in shares) at Sep. 30, 2023		19,299,547
Ending balance at Sep. 30, 2023	17,071	$ 19	150,537	(133,485)
Beginning balance (in shares) at Jun. 30, 2023		19,251,920
Beginning balance at Jun. 30, 2023	17,337	$ 19	150,159	(132,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	381		381
Issuance of shares for vested restricted stock grants (in shares)		47,627
Shares forfeited in exchange for withholding taxes	(3)		(3)
Net loss	(644)			(644)
Ending balance (in shares) at Sep. 30, 2023		19,299,547
Ending balance at Sep. 30, 2023	$ 17,071	$ 19	$ 150,537	$ (133,485)

CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,737)	$ (3,290)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	210	209
Stock-based compensation	1,347	1,768
Allowance for credit losses	23	6
Change in accrued interest and accretion of discount on short-term investments	(154)	0
Changes in assets and liabilities:
(Increase) in accounts receivable	(1,284)	(449)
(Increase) decrease in other current assets and long-term assets	31	176
(Decrease) in accounts payable and accrued expenses	204	(588)
Increase in deferred revenue	1,246	457
Net cash used in operating activities	(1,114)	(1,711)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(68)	(165)
Proceeds from maturity of short-term investments	5,000	0
Purchases of short-term investments	(4,914)	0
Net cash provided by (used in) investing activities	18	(165)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds of insurance financing arrangement	49	0
Withholding taxes paid on RSU vesting	(54)	0
Repayment of insurance financing arrangements	(133)	0
Net cash used in financing activities	(138)	0
Net decrease in cash	(1,234)	(1,876)
CASH, beginning of period	5,196	13,651
CASH, end of period	3,962	11,775
Supplemental disclosures of cash flow information:
Cash paid for interest	2	0
Cash paid for income taxes	$ 78	$ 0

NATURE OF BUSINESS	9 Months Ended
NATURE OF BUSINESS	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF BUSINESS	NATURE OF BUSINESS Business Intellicheck, Inc. (the “Company” or “Intellicheck”) is a prominent technology company engaged in developing, integrating and marketing identity verification solutions to address challenges that include commercial retail and banking fraud prevention. Intellicheck’s products include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices. Intellicheck continues to develop and release innovative products based upon its rich patent portfolio consisting of ten (10) U.S. and one Canadian patents. Liquidity For the nine months ended September 30, 2023, the Company incurred a net loss of $(2,737) and used cash in operations of $(1,114). As of September 30, 2023, the Company had cash and cash equivalents of $3,962, short-term investments of $4,948, working capital (defined as current assets minus current liabilities) of $8,080 and an accumulated deficit of $(133,485). Based on the Company’s business plan and cash resources, Intellicheck expects its existing and future resources and revenues generated from operations to satisfy its working capital requirements for at least the next 12 months from the date of filing.

SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

References in this Quarterly Report on Form 10-Q to “authoritative guidance” is to the Accounting Standards Codification ("ASC") issued by the Financial Accounting Standards Board (“FASB”).

An adjustment has been made to the Consolidated Balance Sheet and Consolidated Statements of Cash Flows for fiscal year ended October 31, 2019, to reclassify the Value Added Tax (VAT) receivable.

For further information, refer to the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

Recent Accounting Pronouncements

Use of Estimates

Research and Development

Allowance for Credit Losses

Cash and Cash Equivalents

Short-term investments

Property and Equipment

Property and equipment are recorded at cost and are depreciated over their estimated useful lives ranging from three to seven years using the straight-line method. See Note 4.

Goodwill

Intangible Assets

Advertising Costs

Retirement Plan

Shipping Costs

Income Taxes

Fair Value of Financial Instruments

The three levels of the fair value hierarchy are as follows:


•Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. The Company's Level 1 assets consisted primarily of cash and cash equivalents as well as short-term investments totaling $8.9 and $10.1 million as of September 30, 2023 and December 31, 2022 respectively.
•Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. The Company had $40 and $54 of Level 2 liabilities as of September 30, 2023 and December 31, 2022 respectively, for the liability-classified stock options. The fair value of these awards were determined by utilizing a Black-Scholes option pricing model.
•Level 3—Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when the fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company had no Level 3 assets or liabilities as of September 30, 2023 and December 31, 2022.

Revenue Recognition and Deferred Revenue

General

Nature of goods and services

Software as a Service (SaaS)

Equipment Revenue

Other Revenue

Disaggregation of revenue

In the following tables, revenue is disaggregated by product and service and the timing of revenue recognition.


	For the Three Months Ended September 30,
	2023		2022
Products and services

Software as a Service (SaaS)	$	4,635	$	3,970
Equipment	106		39
Other	19		3
	$	4,760	$	4,012

Timing of revenue recognition

Products transferred at a point in time	$	125	$	42
Services transferred over time	4,635		3,970
	$	4,760	$	4,012


	For the Nine Months Ended September 30,
	2023		2022
Products and services

Software as a Service (SaaS)	$	13,526	$	11,249
Equipment	152		155
Other	52		11
	$	13,730	$	11,415
Timing of revenue recognition

Products transferred at a point in time	$	204	$	166
Services transferred over time	13,526		11,249
	$	13,730	$	11,415

Contract balances

Accounts Receivable

Transaction price allocated to the remaining performance obligations


	Remainder 2023		2024		2025		Total

Software as a Service (SaaS)	$	427	$	1,721	$	—	$	2,148
Other	5		—		—		5
	$	432	$	1,721	$	—	$	2,153

All consideration from contracts with customers is included in the amounts presented above.

Business Concentrations and Credit Risk

Net Loss Per Share


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Numerator:

Net Loss	$	(644)	$	(724)	$	(2,737)	$	(3,290)

Denominator:
Weighted average common shares –
Basic/Diluted	19,278,295		18,918,596		19,209,620		18,802,892

Net Loss per share –
Basic/Diluted	$	(0.03)	$	(0.04)	$	(0.14)	$	(0.17)

The following table summarizes the common stock equivalents excluded from loss per diluted share because their effect would be anti-dilutive:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Stock options	1,230,905	1,164,676	1,230,905	1,164,676
Restricted stock	73,182	203,492	73,182	203,492
Performance stock units	—	177,688	—	177,688
	1,304,087	1,545,856	1,304,087	1,545,856

Reclassification of Prior Year Presentation

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

9 Months Ended

Sep. 30, 2023

Investments, Debt and Equity Securities [Abstract]

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTSShort-term investments include investments in U.S. treasury notes. Short-term investments with original maturities of approximately three months or less from the date of purchase are classified within cash and cash equivalents. Debt investments with original maturities at the date of purchase greater than approximately three months but less than one year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the company holds are classified as "held-to-maturity". The Company has accounted for and disclosed the purchase of its short-term investments in accordance with ASC 320 ("Investments - Debt Securities"). The following table summarizes the fair value of cash and cash equivalents, and short-term investments as well as any gross unrealized holding gains and losses as of September 30, 2023. Due to the nature of these assets and the short-term nature of

the U.S. treasury notes being held to maturity, both these cash and cash equivalents and short-term investments fall under the Level 1 fair value hierarchy as referenced in Note 2.


	As of September 30, 2023
	Amortized cost		Gross unrealized holding gains		Gross unrealized holding losses		Estimated fair value

Cash and cash equivalents	$	3,962	$	—	$	—	$	3,962
U.S. treasury notes (1)	4,948		—		(5)		4,943
Total cash, cash equivalents and short-term investments	$	8,910	$	—	$	(5)	$	8,905

PROPERTY AND EQUIPMENT

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

PROPERTY AND EQUIPMENT

Property and equipment is summarized as follows:


	September 30, 2023		December 31, 2022
Computer equipment and software	$	1,865	$	1,796
Furniture and fixtures	139		139
Office equipment	614		614
	2,618		2,549
Less – Accumulated depreciation	(1,932)		(1,800)
	$	686	$	749

INTANGIBLE ASSETS

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS

The changes in the carrying amount of intangible assets for the nine months ended September 30, 2023 were as follows:


Net balance at December 31, 2022	$	273
Deduction: Amortization expense	(79)
Net balance at September 30, 2023	$	194

The following tables set forth the components of intangible assets as of September 30, 2023 and December 31, 2022:


		As of September 30, 2023
	Estimated Useful Life	Adjusted Carrying Amount		Accumulated Amortization		Net

Patents and copyrights	2-17 years	$	375	$	(294)	$	81
Developed technology	5 years	400		(287)		113
		$	775	$	(581)	$	194


		As of December 31, 2022
	Estimated Useful Life	Adjusted Carrying Amount		Accumulated Amortization		Net

Patents and copyrights	2-17 years	$	375	$	(275)	$	100
Developed technology	5 years	400		(227)		173
		$	775	$	(502)	$	273

The following summarizes amortization of intangible assets included in the accompanying statements of operations:


	Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of sales	$	24	$	23	$	71	$	71
General and administrative	3		3		8		8
	$	27	$	26	$	79	$	79

DEBT	9 Months Ended
DEBT	Sep. 30, 2023
Debt Disclosure [Abstract]
DEBT	DEBT Revolving Line of Credit On February 6, 2019, the Company entered into a revolving credit facility with Citi Personal Wealth Management that allows for borrowings up to the lesser of (i) $2,000 or (ii) the collateralized balance in the Company’s existing fixed income investment account with Citi Personal Wealth Management subject to certain limitations. The facility bears interest at a rate consistent with Citi Personal Wealth Management’s Base Rate (8.50% and 7.50% at September 30, 2023 and December 31, 2022, respectively) minus 2%. Interest is payable monthly and as of September 30, 2023 and December 31, 2022, there were no amounts outstanding and unused availability under this facility was $2,000. The Company is not subject to any financial covenants related to this revolving line of credit. This line will remain open as long as the Company keeps a depository relationship with the financial institution. Insurance Financing Arrangement On February 2023, the Company entered into a financing arrangement related to insurance premiums totaling $49 with an interest rate of 9.47%. The monthly loan payments of $5 are to be paid to IPFS of New York, LLC over a period of 11 months. As of September 30, 2023, the Company had $14 in remaining commitments related to this financing arrangement which is included within the "Accrued expenses" line within the balance sheet as of September 30, 2023. The Company is not subject to any financial covenants related to this insurance financing arrangement.

ACCRUED EXPENSES

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

ACCRUED EXPENSES

Accrued expenses are comprised of the following:


	September 30, 2023		December 31, 2022
Professional fees	$	110	$	259
Payroll and related	1,536		1,040
Incentive bonuses	617		846
Other	87		174
	$	2,350	$	2,319

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Our available net operating loss (“NOL”) as of December 31, 2022 was approximately $20.8 million, of which $10.9 million expires between 2035 and 2037. In accordance with the Tax Cuts and Jobs Act of 2017 (the "Tax Act"), U.S. NOLs arising in a tax year ending after 2017 will not expire. ASC 740 requires evaluation of uncertain tax positions and as of September 30, 2023, the Company has no material uncertain tax positions. The Company’s interim income tax provision consists of U.S. federal and state income taxes based on the estimated annual effective tax rate that the Company expects for the full year together with the tax effect of discrete items. Each quarter the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as necessary. As of September 30, 2023, the Company was in a pre-tax loss position, and is anticipated to remain so throughout the year. The effective tax rate for the three and nine months ended September 30, 2023 is different from the tax benefit that would result from applying the statutory tax rates primarily due to the recognition of valuation allowances.

STOCKHOLDERS’ EQUITY

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

STOCKHOLDERS' EQUITY

Stock-based Compensation

value based measurement method in accounting for all stock-based compensation payment transactions with employees. All stock-based compensation is included in operating expenses as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Compensation cost recognized:
Selling, general & administrative	$	301	$	561	$	1,125	$	1,270
Research & development	41		168		222		498
	$	342	$	729	$	1,347	$	1,768

Stock Options

Stock option activity under the 2015 Plan during the period indicated below is as follows:


	Number of Shares Subject to Issuance	Weighted- average Exercise Price		Weighted- average Remaining Contractual Term	Aggregate Intrinsic Value

Outstanding at December 31, 2022	1,120,244	$	3.68	3.50 years	$	84
Granted	627,507	2.91		–	–
Forfeited, cancelled, or expired	(516,846)	3.89		–	–
Outstanding at September 30, 2023	1,230,905	$	2.33	3.08 years	$	135

Exercisable at September 30, 2023	593,494	$	3.69	2.10 years	$	73

Restricted Stock Units

Restricted stock unit activity during the period indicated below is as follows:


	Number of Shares	Weighted Average Grant Date Fair Value

Outstanding at December 31, 2022	214,892	$	8.43
Granted	207,306	2.43
Forfeited or surrendered	(70,959)	10.04
Vested and settled in shares	(278,057)	4.42

Outstanding at September 30, 2023	73,182	$	5.11

Performance Stock Units


	Number of Shares	Weighted Average Grant Date Fair Value

Outstanding at December 31, 2022	177,688	$	7.91
Forfeited	(88,844)	7.91
Vested and settled in shares	(88,844)	7.91
Outstanding at September 30, 2023	—	$	7.91

The Company had 1,175,031 shares available for future grants under the Company's equity compensation plans at September 30, 2023.

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES The Company is not aware of any infringement by the Company’s products or technology on the proprietary rights of others. The Company is not currently involved in any legal or regulatory proceeding, or arbitration, the outcome of which is expected to have a material effect on its business. As of September 30, 2023, we are reviewing our historical state sales and use tax liabilities. The Company is subject to sales and use taxes in jurisdictions where it has economic nexus. These reviews, in addition to our conversations with state taxing authorities, may lead to adjustments to the reporting of transactional taxes. We are currently assessing the outcomes that may result from these reviews, which may lead to adjustments to our taxes or net operating losses with respect to the years under review, as well as the current period. We may be subject to additional accruals for the expected outcome of these sales and use tax matters.

SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

References in this Quarterly Report on Form 10-Q to “authoritative guidance” is to the Accounting Standards Codification ("ASC") issued by the Financial Accounting Standards Board (“FASB”).

Recent Accounting Pronouncements

Use of Estimates

Research and Development

Allowance for Credit Losses

Cash and Cash Equivalents

Short-term investments

Short-term investmentsShort-term investments include investments in U.S. treasury notes. Debt investments with original maturities at the date of purchase greater than approximately three months but less than a year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the Company holds are classified as "held-to-maturity".

Property and Equipment

Property and EquipmentProperty and equipment are recorded at cost and are depreciated over their estimated useful lives ranging from three to seven years using the straight-line method.

Goodwill

Intangible Assets

Intangible AssetsIntangible assets include patents, copyrights, and developed technology. The Company amortizes these assets on a straight-line basis over their estimated useful lives, as it represents the pattern of economic benefits consumed. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable in accordance with ASC 360, Property, Plant and Equipment. To determine recoverability of its long-lived assets, the Company evaluates the probability that future undiscounted net cash flows will be less than the carrying amount of the assets.

Advertising Costs

Retirement Plan

Shipping Costs and Revenue Recognition and Deferred Revenue

Shipping Costs

Revenue Recognition and Deferred Revenue

General

Nature of goods and services

Software as a Service (SaaS)

Equipment Revenue

Other Revenue

Income Taxes

Fair Value of Financial Instruments

The three levels of the fair value hierarchy are as follows:


•Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. The Company's Level 1 assets consisted primarily of cash and cash equivalents as well as short-term investments totaling $8.9 and $10.1 million as of September 30, 2023 and December 31, 2022 respectively.
•Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. The Company had $40 and $54 of Level 2 liabilities as of September 30, 2023 and December 31, 2022 respectively, for the liability-classified stock options. The fair value of these awards were determined by utilizing a Black-Scholes option pricing model.
•Level 3—Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when the fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company had no Level 3 assets or liabilities as of September 30, 2023 and December 31, 2022.

Business Concentrations and Credit Risk

Net Loss Per Share

SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Schedule of Revenue Disaggregated by Product and Service and Timing of Revenue Recognition

In the following tables, revenue is disaggregated by product and service and the timing of revenue recognition.


	For the Three Months Ended September 30,
	2023		2022
Products and services

Software as a Service (SaaS)	$	4,635	$	3,970
Equipment	106		39
Other	19		3
	$	4,760	$	4,012

Timing of revenue recognition

Products transferred at a point in time	$	125	$	42
Services transferred over time	4,635		3,970
	$	4,760	$	4,012


	For the Nine Months Ended September 30,
	2023		2022
Products and services

Software as a Service (SaaS)	$	13,526	$	11,249
Equipment	152		155
Other	52		11
	$	13,730	$	11,415
Timing of revenue recognition

Products transferred at a point in time	$	204	$	166
Services transferred over time	13,526		11,249
	$	13,730	$	11,415

Scheduled of Revenue Expected to be Recognized Related to Performance Obligations


	Remainder 2023		2024		2025		Total

Software as a Service (SaaS)	$	427	$	1,721	$	—	$	2,148
Other	5		—		—		5
	$	432	$	1,721	$	—	$	2,153

Schedule of Basic and Diluted Earnings Per Share


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Numerator:

Net Loss	$	(644)	$	(724)	$	(2,737)	$	(3,290)

Denominator:
Weighted average common shares –
Basic/Diluted	19,278,295		18,918,596		19,209,620		18,802,892

Net Loss per share –
Basic/Diluted	$	(0.03)	$	(0.04)	$	(0.14)	$	(0.17)

Summary of Common Stock Equivalents Excluded from Loss Per Diluted Share

The following table summarizes the common stock equivalents excluded from loss per diluted share because their effect would be anti-dilutive:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Stock options	1,230,905	1,164,676	1,230,905	1,164,676
Restricted stock	73,182	203,492	73,182	203,492
Performance stock units	—	177,688	—	177,688
	1,304,087	1,545,856	1,304,087	1,545,856

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)

9 Months Ended

Sep. 30, 2023

Investments, Debt and Equity Securities [Abstract]

Schedule of Cash and Cash Equivalents and Short-Term Investments

The following table summarizes the fair value of cash and cash equivalents, and short-term investments as well as any gross unrealized holding gains and losses as of September 30, 2023. Due to the nature of these assets and the short-term nature of

the U.S. treasury notes being held to maturity, both these cash and cash equivalents and short-term investments fall under the Level 1 fair value hierarchy as referenced in Note 2.


	As of September 30, 2023
	Amortized cost		Gross unrealized holding gains		Gross unrealized holding losses		Estimated fair value

Cash and cash equivalents	$	3,962	$	—	$	—	$	3,962
U.S. treasury notes (1)	4,948		—		(5)		4,943
Total cash, cash equivalents and short-term investments	$	8,910	$	—	$	(5)	$	8,905

PROPERTY AND EQUIPMENT (Tables)

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment is summarized as follows:


	September 30, 2023		December 31, 2022
Computer equipment and software	$	1,865	$	1,796
Furniture and fixtures	139		139
Office equipment	614		614
	2,618		2,549
Less – Accumulated depreciation	(1,932)		(1,800)
	$	686	$	749

INTANGIBLE ASSETS (Tables)

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Changes in Carrying Amount of Intangible Assets

The changes in the carrying amount of intangible assets for the nine months ended September 30, 2023 were as follows:


Net balance at December 31, 2022	$	273
Deduction: Amortization expense	(79)
Net balance at September 30, 2023	$	194

Schedule of Components of Intangible Assets

The following tables set forth the components of intangible assets as of September 30, 2023 and December 31, 2022:


		As of September 30, 2023
	Estimated Useful Life	Adjusted Carrying Amount		Accumulated Amortization		Net

Patents and copyrights	2-17 years	$	375	$	(294)	$	81
Developed technology	5 years	400		(287)		113
		$	775	$	(581)	$	194


		As of December 31, 2022
	Estimated Useful Life	Adjusted Carrying Amount		Accumulated Amortization		Net

Patents and copyrights	2-17 years	$	375	$	(275)	$	100
Developed technology	5 years	400		(227)		173
		$	775	$	(502)	$	273

Schedule of Amortization Expense of Intangible Assets

The following summarizes amortization of intangible assets included in the accompanying statements of operations:


	Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of sales	$	24	$	23	$	71	$	71
General and administrative	3		3		8		8
	$	27	$	26	$	79	$	79

ACCRUED EXPENSES (Tables)

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Expenses

Accrued expenses are comprised of the following:


	September 30, 2023		December 31, 2022
Professional fees	$	110	$	259
Payroll and related	1,536		1,040
Incentive bonuses	617		846
Other	87		174
	$	2,350	$	2,319

STOCKHOLDERS’ EQUITY (Tables)

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Schedule of Stock-Based Compensation Included in Operating Expenses

All stock-based compensation is included in operating expenses as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Compensation cost recognized:
Selling, general & administrative	$	301	$	561	$	1,125	$	1,270
Research & development	41		168		222		498
	$	342	$	729	$	1,347	$	1,768

Schedule of Stock Option Activity

Stock option activity under the 2015 Plan during the period indicated below is as follows:


	Number of Shares Subject to Issuance	Weighted- average Exercise Price		Weighted- average Remaining Contractual Term	Aggregate Intrinsic Value

Outstanding at December 31, 2022	1,120,244	$	3.68	3.50 years	$	84
Granted	627,507	2.91		–	–
Forfeited, cancelled, or expired	(516,846)	3.89		–	–
Outstanding at September 30, 2023	1,230,905	$	2.33	3.08 years	$	135

Exercisable at September 30, 2023	593,494	$	3.69	2.10 years	$	73

Schedule of Restricted Stock Unit (RSU) Activity

Restricted stock unit activity during the period indicated below is as follows:


	Number of Shares	Weighted Average Grant Date Fair Value

Outstanding at December 31, 2022	214,892	$	8.43
Granted	207,306	2.43
Forfeited or surrendered	(70,959)	10.04
Vested and settled in shares	(278,057)	4.42

Outstanding at September 30, 2023	73,182	$	5.11

Schedule of Performance Stock Unit (PSU) Activity


	Number of Shares	Weighted Average Grant Date Fair Value

Outstanding at December 31, 2022	177,688	$	7.91
Forfeited	(88,844)	7.91
Vested and settled in shares	(88,844)	7.91
Outstanding at September 30, 2023	—	$	7.91

NATURE OF BUSINESS (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
NATURE OF BUSINESS (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ (644)	$ (724)	$ (2,737)	$ (3,290)
Net cash used in operations			(1,114)	$ (1,711)
Cash and cash equivalents	3,962		3,962		$ 5,196
Short-term investments	4,948		4,948		4,880
Working capital	8,080		8,080
Accumulated deficit	$ (133,485)		$ (133,485)		$ (130,748)

SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	3 Months Ended		9 Months Ended
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) financial_institution	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Product Information [Line Items]
Goodwill, impairment charges			$ 0	$ 0
Intangible assets, impairment charges	$ 0	$ 0	0	0
Advertising costs	99,000	155,000	470,000	$ 545,000
Equity awards liability	40,000		40,000		$ 54,000
Deferred revenue, current portion	2,153,000		2,153,000		906,000	$ 1,266,000
Revenue recognized	224,000		816,000
Deferred revenue, long-term portion	0		0		1,000	8,000
Accounts receivable, net of allowance for doubtful accounts	3,898,000		3,898,000		2,637,000	2,192,000
Accounts receivable, allowance for doubtful accounts	43,000		$ 43,000		20,000	$ 3,000
Number of financial institutions \| financial_institution			2
Three Customers \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			49.00%	52.00%
Customer One \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			21.00%	22.00%
Customer One \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			38.00%	32.00%
Customer Two \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			14.00%	17.00%
Customer Two \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			3.00%	7.00%
Customer Three \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			14.00%	13.00%
Customer Three \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			5.00%	1.00%
Four Customers \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			58.00%
Customer Four \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent			12.00%	11.00%
Five Customers \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent				70.00%
Customer Five \| Accounts Receivable \| Customer Concentration Risk
Product Information [Line Items]
Business concentration risk, percent				19.00%
Fair Value, Inputs, Level 1
Product Information [Line Items]
Cash, cash equivalents and short-term investments	8,910,000		$ 8,910,000		10,100,000
Fair Value, Inputs, Level 2
Product Information [Line Items]
Equity awards liability	40,000		$ 40,000		$ 54,000
Retirement Savings 401k Plan
Product Information [Line Items]
Retirement plan, maximum employee contribution, percent			35.00%
Retirement plan, employer matching contribution, percent of match			50.00%
Retirement plan, employer matching contribution, percent of employees' gross pay			6.00%
Retirement plan, matching contributions	$ 31,000	$ 30,000	$ 85,000	$ 90,000
Minimum
Product Information [Line Items]
Property and equipment, useful life	3 years		3 years
Maximum
Product Information [Line Items]
Property and equipment, useful life	7 years		7 years

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Product Information [Line Items]
Revenue	$ 4,760	$ 4,012	$ 13,730	$ 11,415
Products transferred at a point in time
Product Information [Line Items]
Revenue	125	42	204	166
Services transferred over time
Product Information [Line Items]
Revenue	4,635	3,970	13,526	11,249
Software as a Service (SaaS)
Product Information [Line Items]
Revenue	4,635	3,970	13,526	11,249
Equipment
Product Information [Line Items]
Revenue	106	39	152	155
Other
Product Information [Line Items]
Revenue	$ 19	$ 3	$ 52	$ 11

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Revenue Performance Obligations (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2,153
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 432
Revenue, remaining performance obligation, period	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 1,721
Revenue, remaining performance obligation, period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	12 months
Software as a Service (SaaS)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2,148
Software as a Service (SaaS) \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 427
Revenue, remaining performance obligation, period	3 months
Software as a Service (SaaS) \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 1,721
Revenue, remaining performance obligation, period	12 months
Software as a Service (SaaS) \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	12 months
Other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 5
Other \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 5
Revenue, remaining performance obligation, period	3 months
Other \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	12 months
Other \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, period	12 months

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net Loss	$ (644)	$ (724)	$ (2,737)	$ (3,290)
Weighted average common shares –
Basic (in shares)	19,278,295	18,918,596	19,209,620	18,802,892
Diluted (in shares)	19,278,295	18,918,596	19,209,620	18,802,892
Net Loss per share –
Basic (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.14)	$ (0.17)
Diluted (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.14)	$ (0.17)

SIGNIFICANT ACCOUNTING POLICIES - Summary of Common Stock Equivalents Excluded from Loss Per Diluted Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from loss per diluted share (in shares)	1,304,087	1,545,856	1,304,087	1,545,856
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from loss per diluted share (in shares)	1,230,905	1,164,676	1,230,905	1,164,676
Restricted stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from loss per diluted share (in shares)	73,182	203,492	73,182	203,492
Performance stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from loss per diluted share (in shares)	0	177,688	0	177,688

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Schedule of Cash and Cash Equivalents and Short Term Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Amortized cost
Cash and cash equivalents	$ 3,962	$ 5,196
Fair Value, Inputs, Level 1
Amortized cost
Cash and cash equivalents	3,962
Total cash, cash equivalents and short-term investments	8,910	$ 10,100
Gross unrealized holding gains
Total cash, cash equivalents and short-term investments	0
Gross unrealized holding losses
Total cash, cash equivalents and short-term investments	(5)
Estimated fair value
Cash and cash equivalents	3,962
Total cash, cash equivalents and short-term investments	8,905
U.S. treasury notes \| Fair Value, Inputs, Level 1
Amortized cost
U.S. treasury notes	4,948
Gross unrealized holding gains
Total cash, cash equivalents and short-term investments	0
Gross unrealized holding losses
Total cash, cash equivalents and short-term investments	(5)
Estimated fair value
U.S. treasury notes	$ 4,943

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Narrative (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2023 USD ($) number_security	Sep. 30, 2022 USD ($) number_security
Schedule of Held-to-Maturity Securities [Line Items]
Short-term investments, matured, realized gains	$ 120
U.S. treasury notes \| Fair Value, Inputs, Level 1
Schedule of Held-to-Maturity Securities [Line Items]
Number of securities in unrealized loss position for more than 12 months \| number_security	0	0
Short-term investments, realized gains or losses	$ 0	$ 0

PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,618	$ 2,549
Less – Accumulated depreciation	(1,932)	(1,800)
Property and equipment, net	686	749
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,865	1,796
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	139	139
Office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 614	$ 614

PROPERTY AND EQUIPMENT - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 45	$ 44	$ 131	$ 131

INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Goodwill [Roll Forward]
Beginning balance			$ 273
Deduction: Amortization expense	$ (27)	$ (26)	(79)	$ (79)
Ending balance	$ 194		$ 194

INTANGIBLE ASSETS - Schedule of Intangible Asset Components (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Adjusted Carrying Amount	$ 775	$ 775
Accumulated Amortization	(581)	(502)
Net	194	273
Patents and copyrights
Finite-Lived Intangible Assets [Line Items]
Adjusted Carrying Amount	375	375
Accumulated Amortization	(294)	(275)
Net	$ 81	$ 100
Patents and copyrights \| Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	2 years	2 years
Patents and copyrights \| Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	17 years	17 years
Developed technology
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	5 years	5 years
Adjusted Carrying Amount	$ 400	$ 400
Accumulated Amortization	(287)	(227)
Net	$ 113	$ 173

INTANGIBLE ASSETS - Schedule of Intangible Assets Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Goodwill [Line Items]
Amortization expense	$ 27	$ 26	$ 79	$ 79
Cost of sales
Goodwill [Line Items]
Amortization expense	24	23	71	71
General and administrative
Goodwill [Line Items]
Amortization expense	$ 3	$ 3	$ 8	$ 8

DEBT (Details) - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
DEBT (Details) - USD ($)	Feb. 28, 2023	Sep. 30, 2023	Dec. 31, 2022	Feb. 06, 2019
Insurance Financing Arrangement, February 2023
Line of Credit Facility [Line Items]
Debt, face amount	$ 49,000
Interest rate	9.47%
Monthly loan payments	$ 5,000
Debt, term	11 months
Remaining commitment		$ 14,000
Citi Personal Wealth Management \| Revolving Credit Facility \| Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity (up to)				$ 2,000,000
Amount outstanding		0	$ 0
Unused availability		$ 2,000,000	$ 2,000,000
Citi Personal Wealth Management \| Revolving Credit Facility \| Line of Credit \| Base Rate \| Variable Rate Component One
Line of Credit Facility [Line Items]
Interest rate, basis spread		8.50%	7.50%
Citi Personal Wealth Management \| Revolving Credit Facility \| Line of Credit \| Base Rate \| Variable Rate Component Two
Line of Credit Facility [Line Items]
Interest rate, basis spread		(2.00%)	(2.00%)

ACCRUED EXPENSES (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Professional fees	$ 110	$ 259
Payroll and related	1,536	1,040
Incentive bonuses	617	846
Other	87	174
Accrued expenses	$ 2,350	$ 2,319

INCOME TAXES (Details) $ in Millions	Dec. 31, 2022 USD ($)
Income Tax Disclosure [Abstract]
Available net operating loss	$ 20.8
Available net operating loss, expires between 2035 and 2037	$ 10.9

STOCKHOLDERS’ EQUITY - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Aug. 07, 2020	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Nov. 04, 2021
Class of Stock [Line Items]
Shares available for future grants (in shares)		1,175,031		1,175,031
Performance Stock Units (PSUs)
Class of Stock [Line Items]
Issued in period (in shares)	265,942
Vesting percentage, based on company's market price percentage	50.00%						100.00%
Vesting percentage, based on company's adjusted EBITDA	50.00%
Outstanding (in shares)		0		0		177,688
Unvested Employee Stock Options and RSUs
Class of Stock [Line Items]
Unrecognized compensation cost		$ 1,028		$ 1,028
Weighted average period of recognition				2 years 3 days
2015 Omnibus Incentive Plan
Class of Stock [Line Items]
Increased (decrease) in stock-based compensation		$ (39)	$ 33	$ (14)	$ (277)
2015 Omnibus Incentive Plan \| Maximum
Class of Stock [Line Items]
Shares authorized (up to) (in shares)		5,236,000		5,236,000
2015 Omnibus Incentive Plan \| Stock options
Class of Stock [Line Items]
Expiration period				10 years
2015 Omnibus Incentive Plan \| Stock options \| Maximum
Class of Stock [Line Items]
Vesting period				4 years
2015 Omnibus Incentive Plan \| Stock options \| Minimum
Class of Stock [Line Items]
Percentage of fair value per share granted (not less than)		110.00%		110.00%
Percentage of grants owning more than voting stock		10.00%		10.00%
Vesting period				1 year

STOCKHOLDERS’ EQUITY - Schedule of Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation cost recognized	$ 342	$ 729	$ 1,347	$ 1,768
Selling, general & administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation cost recognized	301	561	1,125	1,270
Research & development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation cost recognized	$ 41	$ 168	$ 222	$ 498

STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity (Details) - Stock Option Plans - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Number of Shares Subject to Issuance
Outstanding, beginning balance (in shares)	1,120,244
Granted (in shares)	627,507
Forfeited, cancelled, or expired (in shares)	(516,846)
Outstanding, ending balance (in shares)	1,230,905	1,120,244
Exercisable at end of period (in shares)	593,494
Weighted- average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 3.68
Granted (in dollars per share)	2.91
Forfeited, cancelled, or expired (in dollars per share)	3.89
Outstanding, ending balance (in dollars per share)	2.33	$ 3.68
Exercisable at end of period (in dollars per share)	$ 3.69
Weighted- average Remaining Contractual Term
Outstanding	3 years 29 days	3 years 6 months
Exercisable at end of period	2 years 1 month 6 days
Aggregate Intrinsic Value
Outstanding	$ 135	$ 84
Exercisable at end of period	$ 73

STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Unit (RSU) and Performance Stock Unit (PSU) Activity (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Restricted Stock Units (RSUs)
Number of Shares
Outstanding, beginning balance (in shares) \| shares	214,892
Granted (in shares) \| shares	207,306
Forfeited (in shares) \| shares	(70,959)
Vested and settled in shares (in shares) \| shares	(278,057)
Outstanding, ending balance (in shares) \| shares	73,182
Weighted Average Grant Date Fair Value
Outstanding, beginning of period (in dollars per share) \| $ / shares	$ 8.43
Granted (in dollars per share) \| $ / shares	2.43
Forfeited (in dollars per share) \| $ / shares	10.04
Vested and settled in shares (in dollars per share) \| $ / shares	4.42
Outstanding, end of period (in dollars per share) \| $ / shares	$ 5.11
Performance Stock Units (PSUs)
Number of Shares
Outstanding, beginning balance (in shares) \| shares	177,688
Forfeited (in shares) \| shares	(88,844)
Vested and settled in shares (in shares) \| shares	(88,844)
Outstanding, ending balance (in shares) \| shares	0
Weighted Average Grant Date Fair Value
Outstanding, beginning of period (in dollars per share) \| $ / shares	$ 7.91
Forfeited (in dollars per share) \| $ / shares	7.91
Vested and settled in shares (in dollars per share) \| $ / shares	7.91
Outstanding, end of period (in dollars per share) \| $ / shares	$ 7.91